Lanean...
‘No evidence of disease activity’ – is it an appropriate surrogate in multiple sclerosis?
The increasing number of disease‐modifying treatments available for multiple sclerosis has broadened treatment options for patients, but also challenges clinicians to select the best therapy for each individual at the appropriate stage of the disease. Early prediction of treatment response still rem...
Gorde:
| Argitaratua izan da: | Eur J Neurol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6099351/ https://ncbi.nlm.nih.gov/pubmed/29687559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ene.13669 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|